These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 639371)

  • 41. Removal of uraemic toxins by haemofiltration with different membranes. The benefit of regenerating haemofiltrate using a newly developed system.
    Jörstad S; Smeby LC; Wideröe TE; Berg KJ
    Proc Eur Dial Transplant Assoc; 1979; 16():212-7. PubMed ID: 548983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hemodynamic changes during ultrafiltration and hemodialysis in uremia].
    Wehle B; Asaba H; Castenfors J; Fürst P; Gunnarsson B; Bergström J
    Z Urol Nephrol; 1979 Jan; 72(1):3-8. PubMed ID: 425732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Use of hemofiltration in "difficult" uremic patients].
    Alloatti S; Grott G; Triolo G; Quarello F; Segoloni G; Marconetto M; Vercellone A; Piccoli G
    Minerva Nefrol; 1979; 26(3):359-64. PubMed ID: 262275
    [No Abstract]   [Full Text] [Related]  

  • 44. Reduction of treatment time with high flux postdilutional hemofiltration (HF).
    Mion C; Beau MC; Deschodt G; Gullberg CA; Ramperez P; Shaldon S
    Proc Clin Dial Transplant Forum; 1979; 9():63-5. PubMed ID: 552056
    [No Abstract]   [Full Text] [Related]  

  • 45. Hemofiltration: a viable alternative to conventional hemodialysis.
    Pierides AM
    Int J Artif Organs; 1980 Sep; 3(5):253-5. PubMed ID: 7461856
    [No Abstract]   [Full Text] [Related]  

  • 46. Does convective dialysis therapy applied daily approach renal blood purification?
    Ledebo I
    Kidney Int Suppl; 2001 Feb; 78():S286-91. PubMed ID: 11169028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemodialysis or hemofiltration--the patients' view.
    Hüfler M; Asmus G; von Herrath D; Schaefer K
    Blood Purif; 1987; 5(1):1-3. PubMed ID: 3790267
    [No Abstract]   [Full Text] [Related]  

  • 48. The Rationale for Expanded Hemodialysis Therapy (HDx).
    Hutchison CA; Wolley M
    Contrib Nephrol; 2017; 191():142-152. PubMed ID: 28910797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current status of hemofiltration.
    Henderson LW
    Artif Organs; 1978 May; 2(2):120-4. PubMed ID: 687163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The use of an ultrafiltration control monitor in patients treated with intermittent hemodialysis (proceedings)].
    Rottembourg J; Jacq D; Durande JP; Rojas P
    J Urol Nephrol (Paris); 1979; 85(4-5):340. PubMed ID: 480451
    [No Abstract]   [Full Text] [Related]  

  • 51. Continuous arteriovenous hemodialysis and hemofiltration in acute renal failure: comparison of uremic control.
    Alarabi AA; Wikström B; Danielson BG
    Contrib Nephrol; 1991; 93():61-4. PubMed ID: 1802603
    [No Abstract]   [Full Text] [Related]  

  • 52. Failure of platelet markers to evaluate membrane biocompatibility during a combined hemodialysis-hemoperfusion treatment.
    Buccianti G; Giaretto S; Pogliani EM; Lorenz M; Valenti G; Bianchi ML; Cresseri D
    Artif Organs; 1987 Oct; 11(5):416-20. PubMed ID: 2961320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Technical requirements for rapid high-efficiency therapy in uremic patients. Paired filtration-dialysis (PFD) with a two-chamber technique.
    Ghezzi PM; Sanz-Moreno C; Gervasio R; Nigrelli S; Botella J
    ASAIO Trans; 1987; 33(3):546-50. PubMed ID: 3675986
    [No Abstract]   [Full Text] [Related]  

  • 54. High flux hemofiltration.
    Bosch JP; Geronemus R; Glabman S; Lysaght M; Kahn T; von Albertini B
    Artif Organs; 1978 Nov; 2(4):339-42. PubMed ID: 743001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Recent advances and prospects in periodic hemodialytic treatment for patients with uremia].
    Campanacci L; Huber W
    Minerva Med; 1976 Jul; 67(34):2151-60. PubMed ID: 59909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of serum osmolarity, arterial blood pressure and volume loss on IOP during hemodialysis, hemofiltration and simultaneous hemofiltration/hemodialysis (author's transl)].
    Wizemann A; Bernhardt O; Wizemann V
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1980; 213(1):43-7. PubMed ID: 6906145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A one-dimensional model of simultaneous hemodialysis and ultrafiltration with highly permeable membranes.
    Jaffrin MY; Gupta BB; Malbrancq JM
    J Biomech Eng; 1981 Nov; 103(4):261-6. PubMed ID: 7311492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced protein loss during hemofiltration using Cuprophan membranes.
    Rubin JE; Adler AJ; Friedman EA; Berlyne GM
    Artif Organs; 1978 May; 2(2):131-3. PubMed ID: 687166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma volume changes induced by sequential ultrafiltration-hemodialysis and sequential hemodialysis-ultrafiltration.
    Di Maggio A; Basile C; Scatizzi A
    Int J Artif Organs; 1987 Sep; 10(5):291-4. PubMed ID: 3679570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of different dialyzer membranes on plasma fibronectin levels in hemodialyzed patients.
    Pertosa G; Pastore A; Schena FP
    Int J Artif Organs; 1989 Jan; 12(1):36-40. PubMed ID: 2925259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.